AR010643A1 - Compuestos de 2-imidazolinilaminoindazol, composicion farmaceutica que lo contiene y uso de dicho compuesto para la fabricacion de un medicamento. - Google Patents

Compuestos de 2-imidazolinilaminoindazol, composicion farmaceutica que lo contiene y uso de dicho compuesto para la fabricacion de un medicamento.

Info

Publication number
AR010643A1
AR010643A1 ARP970105524A ARP970105524A AR010643A1 AR 010643 A1 AR010643 A1 AR 010643A1 AR P970105524 A ARP970105524 A AR P970105524A AR P970105524 A ARP970105524 A AR P970105524A AR 010643 A1 AR010643 A1 AR 010643A1
Authority
AR
Argentina
Prior art keywords
hydrogen
compounds
compound
unsubstituted
manufacture
Prior art date
Application number
ARP970105524A
Other languages
English (en)
Spanish (es)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of AR010643A1 publication Critical patent/AR010643A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
ARP970105524A 1996-11-25 1997-11-25 Compuestos de 2-imidazolinilaminoindazol, composicion farmaceutica que lo contiene y uso de dicho compuesto para la fabricacion de un medicamento. AR010643A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3174096P 1996-11-25 1996-11-25

Publications (1)

Publication Number Publication Date
AR010643A1 true AR010643A1 (es) 2000-06-28

Family

ID=21861136

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105524A AR010643A1 (es) 1996-11-25 1997-11-25 Compuestos de 2-imidazolinilaminoindazol, composicion farmaceutica que lo contiene y uso de dicho compuesto para la fabricacion de un medicamento.

Country Status (20)

Country Link
EP (1) EP0944620A1 (id)
JP (1) JP2001506599A (id)
KR (1) KR20000069104A (id)
CN (1) CN1244864A (id)
AR (1) AR010643A1 (id)
AU (1) AU5433998A (id)
BR (1) BR9713535A (id)
CA (1) CA2272644A1 (id)
CO (1) CO4910166A1 (id)
CZ (1) CZ183999A3 (id)
HU (1) HUP9904660A3 (id)
ID (1) ID22676A (id)
IL (1) IL130067A0 (id)
NO (1) NO992502L (id)
NZ (1) NZ335882A (id)
PE (1) PE47099A1 (id)
SK (1) SK69699A3 (id)
TR (1) TR199901542T2 (id)
WO (1) WO1998023609A1 (id)
ZA (1) ZA9710576B (id)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
US6433186B1 (en) 2000-08-16 2002-08-13 Astrazeneca Ab Amidino derivatives and their use as thormbin inhibitors
EP2226315A4 (en) 2007-12-28 2012-01-25 Carna Biosciences Inc 2-aminoquinazoline DERIVATIVE
WO2010074753A1 (en) 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CN112538074A (zh) * 2020-12-24 2021-03-23 艾希尔(深圳)药物研发有限公司 一种溴莫尼定脱溴杂质的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH641782A5 (en) * 1978-12-07 1984-03-15 Siegfried Ag 1H- and 2H-indazole derivatives
US4526898A (en) * 1980-09-05 1985-07-02 Siegfried Aktiengesselschaft Antihypertensive 4-(2-imidazolin-2-yl-amino)-2-methyl-indazole
US5478858A (en) * 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
SG44628A1 (en) * 1993-12-17 1997-12-19 Procter & Gamble 6-(2-imidazolinylamino) Quinoxaline compounds useful as alpha-2 adrenoceptor agonists

Also Published As

Publication number Publication date
IL130067A0 (en) 2000-02-29
WO1998023609A1 (en) 1998-06-04
SK69699A3 (en) 2000-06-12
CZ183999A3 (cs) 1999-11-17
CA2272644A1 (en) 1998-06-04
HUP9904660A3 (en) 2002-02-28
CO4910166A1 (es) 2000-04-24
BR9713535A (pt) 2000-03-21
CN1244864A (zh) 2000-02-16
NZ335882A (en) 2000-12-22
ID22676A (id) 1999-12-09
PE47099A1 (es) 1999-06-12
NO992502L (no) 1999-07-26
ZA9710576B (en) 1998-09-16
TR199901542T2 (xx) 2000-01-21
NO992502D0 (no) 1999-05-25
HUP9904660A2 (hu) 2000-06-28
JP2001506599A (ja) 2001-05-22
KR20000069104A (ko) 2000-11-25
EP0944620A1 (en) 1999-09-29
AU5433998A (en) 1998-06-22

Similar Documents

Publication Publication Date Title
AR013875A1 (es) Compuesto 2-imidazolinilaminoindol, composicion farmaceutica que comprende dicho compuesto y uso del mismo para la fabricacion de un medicamento.
BR0010555A (pt) Inibidores de neuraminidases
CO4810373A1 (es) Compuestos azapoliciclicos condensados con arilo
ES2163071T3 (es) Sulfonamidas y su utilizacion.
DK0705254T3 (da) Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer
YU54896A (sh) (methilsulfonil)fenil-2-(5h)-furanoni kao cox-2 inhibitori
BR0312999A (pt) Compostos, composições farmacêticas, método para aumentar a cognição, de tratamento, de inibição da atividade de enzima pde4 em um paciente
AR009145A1 (es) Compuetos heterociclicos de guanidinilo utiles como agonistas de alfa-2 adrenoreceptores y composiciones farmaceuticas que los comprenden
DK0778834T3 (da) Bicykliske, heterocykliske diarylforbindelser som inhibitorer af cyclooxygenase-2
ES2121896T3 (es) Derivados de acido hidroxamico como inhibidores de colagenasa.
UY25780A1 (es) Nuevos antibióticos macrólidos
AR022019A1 (es) Un compuesto de imidazol y las composiciones farmaceuticas que lo contienen
CO4910150A1 (es) Compuestos de 2-imidazolinilaminobenzoxazol utiles con agonistas de alfa-2 adrenoceptores
PA8471301A1 (es) Compuestos azapoliciclicos condensados con arilo
AR010643A1 (es) Compuestos de 2-imidazolinilaminoindazol, composicion farmaceutica que lo contiene y uso de dicho compuesto para la fabricacion de un medicamento.
AR029461A1 (es) Derivados de 4-fenil-1-piperazinilo, - piperidinilo y -tetrahidropiridilo , composiciones farmaceuticas que los comprenden y el uso de los mismos para la fabricacion de un medicamento
AR017146A1 (es) Compuestos de 1-(fenil-sustituido)-5-(4-metilsulfonilfenil)pirazol; procedimiento para prepararlos, las composiciones farmaceuticas que los contienen,los agentes inhibidores de la cox-ii que los contienen y el uso de dichos compuestos para la fabricacion de medicamentos.
BR9911250A (pt) Processo para preparação de compostos
BR0313000A (pt) Compostos, composição farmacêutica e método para efetuar a inibição da enzima pde4, realçar a cognição e/ou tratar a psicose em um paciente
DE60104986D1 (de) Xanthinderivate, zwischenprodukte und verwendung zur behandlung von osteoporosis
UY26147A1 (es) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinil-aminometilcromano.
BRPI0204489B8 (pt) "derivado de rodamina, composição farmacêutica, intermediário, e, processo para a síntese de novos derivados rodamina".
ES2094638T3 (es) N-acilpirrolidinas y medicamentos para el tratamiento o la prevencion de los desordenes relacionados con la colecistoquinina y la gastrina.
AR009144A1 (es) Compuestos heterociclicos guanidilamino, composicion farmaceutica que comprende dicho compuesto y uso del mismo para la fabricacion de un medicamento
PE16199A1 (es) Compuestos de 2-imidazolinilaminobenzotiazol utiles como agonistas de alfa-2 adrenoreceptores